Works matching IS 02683369 AND DT 2011 AND VI 46 AND IP 3

Results: 31

Inflammatory cytokine inhibition with combination daclizumab and infliximab for steroid-refractory acute GVHD.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 3, p. 430, doi. 10.1038/bmt.2010.117

By:

Rager, A.;
Frey, N.;
Goldstein, S. C.;
Reshef, R.;
Hexner, E. O.;
Loren, A.;
Luger, S. M.;
Perl, A.;
Tsai, D.;
Davis, J.;
Vozniak, M.;
Smith, J.;
Stadtmauer, E. A.;
Porter, D. L.

Publication type:

Article

The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSF.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 3, p. 356, doi. 10.1038/bmt.2010.128

By:

D'Addio, A.;
Curti, A.;
Worel, N.;
Douglas, K.;
Motta, M. R.;
Rizzi, S.;
Dan, E.;
Taioli, S.;
Giudice, V.;
Agis, H.;
Kopetzky, G.;
Soutar, R.;
Casadei, B.;
Baccarani, M.;
Lemoli, R. M.

Publication type:

Article

Air-leak syndrome following allo-SCT in adult patients: report from the Kanto Study Group for Cell Therapy in Japan.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 3, p. 379, doi. 10.1038/bmt.2010.129

By:

Sakai, R.;
Kanamori, H.;
Nakaseko, C.;
Yoshiba, F.;
Fujimaki, K.;
Sakura, T.;
Fujisawa, S.;
Kawai, N.;
Onoda, M.;
Matsushima, T.;
Maruta, A.;
Sakamaki, H.;
Okamoto, S.

Publication type:

Article

Regulatory T cell expression of CLA or α4β7 and skin or gut acute GVHD outcomes.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 3, p. 436, doi. 10.1038/bmt.2010.127

By:

Engelhardt, B. G.;
Jagasia, M.;
Savani, B. N.;
Bratcher, N. L.;
Greer, J. P.;
Jiang, A.;
Kassim, A. A.;
Lu, P.;
Schuening, F.;
Yoder, S. M.;
Rock, M. T.;
Crowe, J. E.

Publication type:

Article

Lower leukemia relapse in pediatric patients with pulmonary cytolytic thrombi following allogeneic transplant.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 3, p. 368, doi. 10.1038/bmt.2010.119

By:

Smith, A. R.;
Gulbahce, E.;
Burke, M. J.;
Cao, Q.;
MacMillan, M. L.;
Tolar, J.;
Orchard, P. J.;
Blazar, B. R.;
Baker, K. S.;
Wagner, J. E.;
Verneris, M. R.

Publication type:

Article

High probability of long-term survival in 2-year survivors of autologous hematopoietic cell transplantation for AML in first or second CR.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 3, p. 385, doi. 10.1038/bmt.2010.115

By:

Majhail, N. S.;
Bajorunaite, R.;
Lazarus, H. M.;
Wang, Z.;
Klein, J. P.;
Zhang, M. J.;
Rizzo, J. D.

Publication type:

Article

Relationship between TNFA, TNFB and TNFRII gene polymorphisms and outcome after unrelated hematopoietic cell transplantation in a Chinese population.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 3, p. 400, doi. 10.1038/bmt.2010.135

By:

Xiao, H. W.;
Lai, X. Y.;
Luo, Y.;
Shi, J. M.;
Tan, Y. M.;
He, J. S.;
Xie, W. Z.;
Li, L.;
Zhu, X. L.;
Zhu, J. J.;
Sun, J.;
Wei, G. Q.;
Jin, L.;
Liu, L. Z.;
Wu, K. N.;
Yu, X. H.;
Cai, Z.;
Lin, M. F.;
Ye, X. J.;
Huang, H.

Publication type:

Article

The Mexican Way: a feasible approach to avoid DMSO toxicity.

Published in:

2011

By:

Schroeder, T.;
Fenk, R.;
Saure, C.;
Czibere, A.;
Bruns, I.;
Zohren, F.;
Haas, R.;
Kobbe, G.

Publication type:

Letter

Autologous hematopoietic cell transplantation for high-risk ALL.

Published in:

2011

By:

Linker, C.;
Damon, L.;
Martin, T.;
Blume, K.;
Forman, S.;
Snyder, D.;
Wolf, J.;
Negrin, R.

Publication type:

Letter

High incidence of fatty liver and insulin resistance in long-term adult survivors of childhood SCT.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 3, p. 416, doi. 10.1038/bmt.2010.144

By:

Tomita, Y.;
Ishiguro, H.;
Yasuda, Y.;
Hyodo, H.;
Koike, T.;
Shimizu, T.;
Morimoto, T.;
Hattori, K.;
Matsumoto, M.;
Inoue, H.;
Yabe, H.;
Yabe, M.;
Shinohara, O.;
Kojima, S.;
Minemura, T.;
Kato, S.

Publication type:

Article

Plerixafor (Mozobil) for stem cell mobilization in patients with multiple myeloma previously treated with lenalidomide.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 3, p. 350, doi. 10.1038/bmt.2010.118

By:

Micallef, I. N. M.;
Ho, A. D.;
Klein, L. M.;
Marulkar, S.;
Gandhi, P. J.;
McSweeney, P. A.

Publication type:

Article

The great debate: haploidentical or cord blood transplant.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 3, p. 323, doi. 10.1038/bmt.2010.260

By:

Ballen, K. K.;
Spitzer, T. R.

Publication type:

Article

Long-term remission in pediatric Wegener granulomatosis following allo-SCT after reduced-intensity conditioning.

Published in:

2011

By:

Lawitschka, A.;
Peters, C.;
Seidel, M. G.;
Havranek, A.;
Heitger, A.;
Fazekas, T.;
Gueclue, E. D.;
Gadner, H.;
Matthes-Martin, S.

Publication type:

Letter

Transient chromosomal rearrangements in three children with acute lymphoblastic leukemia after unrelated cord blood transplantation.

Published in:

2011

By:

Otero, L.;
de Souza Fernandez, T.;
Padilha, T. F.;
Carestiato, F. N.;
Bouzas, L. F.;
Abdelhay, E.

Publication type:

Letter

Prospective comparison of PCR-based vs late mRNA-based preemptive antiviral therapy for HCMV infection in patients after allo-SCT.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 3, p. 408, doi. 10.1038/bmt.2010.136

By:

Hebart, H.;
Lengerke, C.;
Ljungman, P.;
Paya, C. V.;
Klingebiel, T.;
Loeffler, J.;
Pfaffenrath, S.;
Lewensohn-Fuchs, I.;
Barkholt, L.;
Tomiuk, J.;
Meisner, C.;
Lunenberg, J.;
Top, B.;
Razonable, R. R.;
Patel, R.;
Litzow, M. R.;
Jahn, G.;
Einsele, H.

Publication type:

Article

Use of intrathecal chemoprophylaxis in children after SCT and the risk of central nervous system relapse.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 3, p. 372, doi. 10.1038/bmt.2010.121

By:

Rubin, J.;
Vettenranta, K.;
Vettenranta, J.;
Bierings, M.;
Abrahamsson, J.;
Békássy, A. N.;
Håkansson, Y.;
Frost, B.-M.;
Arvidson, J.;
Spendilow, C.;
Winiarski, J.;
Gustafsson, B.

Publication type:

Article

Late onset cytomegalovirus encephalitis after reduced-intensity conditioning allogeneic SCT: an emerging neurological complication?

Published in:

2011

By:

Candoni, A.;
Simeone, E.;
Buttignol, S.;
Volpetti, S.;
Lazzarotto, T.;
Pipan, C.;
Fanin, R.

Publication type:

Letter

Rapid response to IFN-α in a patient with relapsed follicular lymphoma after cord blood transplantation.

Published in:

2011

By:

Arima, N.;
Yoshinaga, N.;
Maruyama, W.;
Fukunaga, A.;
Hirata, H.;
Uchiyama, T.

Publication type:

Letter

Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-SCT.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 3, p. 426, doi. 10.1038/bmt.2010.152

By:

Lucid, C. E.;
Savani, B. N.;
Engelhardt, B. G.;
Shah, P.;
Clifton, C.;
Greenhut, S. L.;
Vaughan, L. A.;
Kassim, A.;
Schuening, F.;
Jagasia, M.

Publication type:

Article

Assignment of scores for the hematopoietic cell transplantation comorbidity index: integer vs exact weights.

Published in:

2011

By:

Sorror, M. L.;
Storer, B.;
Storb, R.

Publication type:

Letter

Pandemic influenza A H1N1/09 virus infection in hematopoietic SCT recipient.

Published in:

2011

By:

Bastos, D. A.;
Rodrigues, C. A.;
Patah, P.;
Kallas, E. G.;
Rocha, V.;
Novis, Y.

Publication type:

Letter

Auto-SCT in severe paraproteinemic neuropathy.

Published in:

2011

By:

Hummel, H. D.;
Rath, J. C.;
Wiendl, H.;
Hetzel, W.;
Bargou, R. C.;
Toyka, K. V.;
Sommer, C.;
Einsele, H.;
Topp, M. S.

Publication type:

Letter

Impact of the European Clinical Trials Directive on prospective academic clinical trials associated with BMT.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 3, p. 443, doi. 10.1038/bmt.2010.139

By:

Frewer, L. J.;
Coles, D.;
van der Lans, I. A.;
Schroeder, D.;
Champion, K.;
Apperley, J. F.

Publication type:

Article

Drug interaction between voriconazole and tacrolimus in allogeneic hematopoietic SCT recipients.

Published in:

2011

By:

Mori, T.;
Kato, J.;
Yamane, A.;
Ono, Y.;
Shimizu, T.;
Okamoto, S.

Publication type:

Letter

Thoracoscopic surgery using local and epidural anesthesia for intractable pneumothorax after BMT.

Published in:

2011

By:

Shigematsu, H.;
Andou, A.;
Matsuo, K.;
Satoh, T.;
Higashi, R.

Publication type:

Letter

Order of application and liver toxicity in patients given BU and CY containing conditioning regimens for allogeneic hematopoietic SCT.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 3, p. 344, doi. 10.1038/bmt.2010.137

By:

Cantoni, N.;
Gerull, S.;
Heim, D.;
Halter, J.;
Bucher, C.;
Buser, A.;
Tsakiris, D. A.;
Passweg, J.;
Tichelli, A.;
Stern, M.;
Gratwohl, A.

Publication type:

Article

Impact of high-dose chemotherapy followed by auto-SCT for positive interim [18F] FDG-PET diffuse large B-cell lymphoma patients.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 3, p. 393, doi. 10.1038/bmt.2010.130

By:

Roland, V.;
Bodet-Milin, C.;
Moreau, A.;
Gastinne, T.;
Mahé, B.;
Dubruille, V.;
Maisonneuve, H.;
Juge-Morineau, N.;
Moreau, P.;
Jardel, H.;
Planche, L.;
Mohty, M.;
Harousseau, J.-L.;
Kraeber-Bodéré, F.;
Le Gouill, S.

Publication type:

Article

World Marrow Donor Association framework for the implementation of HLA matching programs in hematopoietic stem cell donor registries and cord blood banks.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 3, p. 338, doi. 10.1038/bmt.2010.132

By:

Bochtler, W.;
Maiers, M.;
Bakker, J. N. A.;
Oudshoorn, M.;
Marsh, S. G. E.;
Baier, D.;
Hurley, C. K.;
Müller, C. R.

Publication type:

Article

High rate of stem cell mobilization failure after thalidomide and oral cyclophosphamide induction therapy for multiple myeloma.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 3, p. 364, doi. 10.1038/bmt.2010.141

By:

Auner, H. W.;
Mazzarella, L.;
Cook, L.;
Szydlo, R.;
Saltarelli, F.;
Pavlu, J.;
Bua, M.;
Giles, C.;
Apperley, J. F.;
Rahemtulla, A.

Publication type:

Article

Hematopoietic Stem Cell Biology.

Published in:

2011

By:

So, C. W. E.

Publication type:

Book Review

Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approach.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 3, p. 330, doi. 10.1038/bmt.2010.100

By:

Halter, J.;
Schüpbach, W. M. M.;
Casali, C.;
Elhasid, R.;
Fay, K.;
Hammans, S.;
Illa, I.;
Kappeler, L.;
Krähenbühl, S.;
Lehmann, T.;
Mandel, H.;
Marti, R.;
Mattle, H.;
Orchard, K.;
Savage, D.;
Sue, C. M.;
Valcarcel, D.;
Gratwohl, A.;
Hirano, M.

Publication type:

Article

Works matching IS 02683369 AND DT 2011 AND VI 46 AND IP 3

Inflammatory cytokine inhibition with combination daclizumab and infliximab for steroid-refractory acute GVHD.

The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSF.

Air-leak syndrome following allo-SCT in adult patients: report from the Kanto Study Group for Cell Therapy in Japan.

Regulatory T cell expression of CLA or α<sub>4</sub>β<sub>7</sub> and skin or gut acute GVHD outcomes.

Lower leukemia relapse in pediatric patients with pulmonary cytolytic thrombi following allogeneic transplant.

High probability of long-term survival in 2-year survivors of autologous hematopoietic cell transplantation for AML in first or second CR.

Relationship between TNFA, TNFB and TNFRII gene polymorphisms and outcome after unrelated hematopoietic cell transplantation in a Chinese population.

The Mexican Way: a feasible approach to avoid DMSO toxicity.

Autologous hematopoietic cell transplantation for high-risk ALL.

High incidence of fatty liver and insulin resistance in long-term adult survivors of childhood SCT.

Plerixafor (Mozobil) for stem cell mobilization in patients with multiple myeloma previously treated with lenalidomide.

The great debate: haploidentical or cord blood transplant.

Long-term remission in pediatric Wegener granulomatosis following allo-SCT after reduced-intensity conditioning.

Transient chromosomal rearrangements in three children with acute lymphoblastic leukemia after unrelated cord blood transplantation.

Prospective comparison of PCR-based vs late mRNA-based preemptive antiviral therapy for HCMV infection in patients after allo-SCT.

Use of intrathecal chemoprophylaxis in children after SCT and the risk of central nervous system relapse.

Late onset cytomegalovirus encephalitis after reduced-intensity conditioning allogeneic SCT: an emerging neurological complication?

Rapid response to IFN-α in a patient with relapsed follicular lymphoma after cord blood transplantation.

Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-SCT.

Assignment of scores for the hematopoietic cell transplantation comorbidity index: integer vs exact weights.

Pandemic influenza A H1N1/09 virus infection in hematopoietic SCT recipient.

Auto-SCT in severe paraproteinemic neuropathy.

Impact of the European Clinical Trials Directive on prospective academic clinical trials associated with BMT.

Drug interaction between voriconazole and tacrolimus in allogeneic hematopoietic SCT recipients.

Thoracoscopic surgery using local and epidural anesthesia for intractable pneumothorax after BMT.

Order of application and liver toxicity in patients given BU and CY containing conditioning regimens for allogeneic hematopoietic SCT.

Impact of high-dose chemotherapy followed by auto-SCT for positive interim [<sup>18</sup>F] FDG-PET diffuse large B-cell lymphoma patients.

World Marrow Donor Association framework for the implementation of HLA matching programs in hematopoietic stem cell donor registries and cord blood banks.

High rate of stem cell mobilization failure after thalidomide and oral cyclophosphamide induction therapy for multiple myeloma.

Hematopoietic Stem Cell Biology.

Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approach.